This Article Full Text Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Limor, R. Articles by Stern, N. Search for Related Content PubMed PubMed Citation Articles by Limor, R. Articles by Stern, N. Related Collections Cell biology/structural biology Gene expression Hypertension - basic studies Aggregation Other Vascular biology

(Hypertension. 2001;38:864.)
© 2001 American Heart Association, Inc.

Scientific Contributions

A Novel Form of Platelet-Type 12-Lipoxygenase mRNA in Human Vascular Smooth Muscle Cells

Rona Limor; Gary Weisinger; Suzan Gilad; Esther Knoll; Orly Sharon; Anat Jaffe; Fortuna Kohen; Esther Berger; Beatriz Lifschizt-Mercer; Naftali Stern

From the Institute of Endocrinology, Metabolism and Hypertension (R.L., G.W., S.G., E.K., O.S., A.J., N.S.) and Department of Pathology (E.B., B.L.-M.), Tel Aviv-Souraski Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and Department of Biological Regulation, Weizman Institute of Science (F.K.), Rehovot, Israel.

Correspondence to Naftali Stern, Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv-Souraski Medical Center, 6 Weizman St, Tel Aviv, Israel.

Abstract—— The lipoxygenase pathway has been implicated in the growth, migration, and contraction of vascular smooth muscle cells (VSMCs). However, the precise type of lipoxygenase present in the vascular wall has not been characterized. In this study, we used a specific reverse-transcriptase polymerase chain reaction method with 2 sets of specific primers on total RNA and polyA (+)RNA of normal human VSMCs prepared from umbilical artery. Two forms of platelet-type 12-lipoxygenase mRNA were present in human VSMCs: the already published form cloned from human erythroleukemia cells and a variant form of platelet-type 12-lipoxygenase, which includes 2 additional sequences consistent with the 2 introns (D and E). This novel form of 12-lipoxygenase poly A (+)RNA was downregulated by lipopolysaccharide (10 µg/mL) and upregulated by epidermal growth factor (100 ng/mL) but was not affected by angiotensin II (10^-7 mol/L). We developed a rabbit anti-human platelet-type 12-lipoxygenase polyclonal antibody directed against a 24-amino acid peptide encoded within exon 4. Western immunoblotting of protein extracted from VSMCs and umbilical artery and platelet extract with this antibody showed a coordinate 110-kDa protein and the already-described 70-kDa band detected in platelets and cord homogenate. Another 120-kDa protein was consistently detected in cord extracts but not in platelet or VSMC homogenates. The immunohistochemistry study performed with the same antibody showed extensive cytoplasmic staining of VSMCs. The specific role of these different forms of platelet-type 12-lipoxygenase is subject to further investigation.

Key Words: lipoxygenase • muscle, smooth, vascular • atherosclerosis

This article has been cited by other articles:

				M. A. Reddy, Y.-S. Kim, L. Lanting, and R. Natarajan Reduced Growth Factor Responses in Vascular Smooth Muscle Cells Derived from 12/15-Lipoxygenase-Deficient Mice Hypertension, June 1, 2003; 41(6): 1294 - 1300. [Abstract] [Full Text] [PDF]